| Nome |
# |
|
Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial., file dfe4d22c-0880-bb0a-e053-d805fe0a78d9
|
1.024
|
|
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair, file 12e43767-a2b5-447e-892d-246153f464b1
|
1.006
|
|
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score, file dfe4d22b-cd61-bb0a-e053-d805fe0a78d9
|
809
|
|
Effectiveness of MitraClip Therapy in Patients with Refractory Heart Failure, file dfe4d22b-c599-bb0a-e053-d805fe0a78d9
|
784
|
|
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture, file dfe4d22a-6ff4-bb0a-e053-d805fe0a78d9
|
172
|
|
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold, file dfe4d22a-78c7-bb0a-e053-d805fe0a78d9
|
171
|
|
Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure, file dfe4d22b-ebfa-bb0a-e053-d805fe0a78d9
|
55
|
|
Ventricular Arrhythmias in Aortic Valve Stenosis Before and After Transcatheter Aortic Valve Implantation, file dfe4d22a-7f3d-bb0a-e053-d805fe0a78d9
|
51
|
|
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry), file dfe4d22b-7e5f-bb0a-e053-d805fe0a78d9
|
51
|
|
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the
GHOST-EU and XIENCE V USA Registries, file dfe4d22b-dd29-bb0a-e053-d805fe0a78d9
|
44
|
|
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients., file dfe4d22a-ef5d-bb0a-e053-d805fe0a78d9
|
43
|
|
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5, file dfe4d22c-2bd1-bb0a-e053-d805fe0a78d9
|
42
|
|
MitraClip Implantation for the Treatment of New-Onset Systolic Anterior Motion of the Mitral Valve After Transcatheter Aortic Valve Replacement, file dfe4d22b-7e6e-bb0a-e053-d805fe0a78d9
|
41
|
|
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry., file dfe4d22b-daa7-bb0a-e053-d805fe0a78d9
|
40
|
|
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction, file dfe4d22c-2708-bb0a-e053-d805fe0a78d9
|
32
|
|
Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study., file dfe4d22c-28b3-bb0a-e053-d805fe0a78d9
|
32
|
|
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients, file dfe4d22b-e534-bb0a-e053-d805fe0a78d9
|
31
|
|
1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study, file dfe4d22b-d7dd-bb0a-e053-d805fe0a78d9
|
30
|
|
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey, file dfe4d22b-e1cf-bb0a-e053-d805fe0a78d9
|
26
|
|
Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation., file dfe4d229-85a3-bb0a-e053-d805fe0a78d9
|
24
|
|
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry., file dfe4d22b-ea53-bb0a-e053-d805fe0a78d9
|
23
|
|
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement, file dfe4d22e-8c1a-bb0a-e053-d805fe0a78d9
|
21
|
|
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death., file dfe4d22c-1103-bb0a-e053-d805fe0a78d9
|
20
|
|
Coronary Cannulation After Transcatheter Aortic Valve Replacement The RE-ACCESS Study, file dfe4d22e-649e-bb0a-e053-d805fe0a78d9
|
19
|
|
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry, file dfe4d22b-7e5e-bb0a-e053-d805fe0a78d9
|
18
|
|
Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry, file dfe4d22b-a5e2-bb0a-e053-d805fe0a78d9
|
18
|
|
Severe aortic valve stenosis: Symptoms, biochemical markers, and global longitudinal strain., file dfe4d22d-c0cc-bb0a-e053-d805fe0a78d9
|
18
|
|
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis, file dfe4d22b-db7d-bb0a-e053-d805fe0a78d9
|
17
|
|
Transcatheter Aortic-Valve Replacement, file dfe4d22b-8025-bb0a-e053-d805fe0a78d9
|
16
|
|
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), file dfe4d22b-f769-bb0a-e053-d805fe0a78d9
|
16
|
|
Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis Patients Undergoing Chronic Dialysis, file dfe4d22b-d967-bb0a-e053-d805fe0a78d9
|
15
|
|
Reply: TAVI in Lower Risk Patients: Revolution or Nonsense? Keep Calm and Select Patients., file dfe4d22a-dd51-bb0a-e053-d805fe0a78d9
|
14
|
|
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation), file dfe4d22b-7e5d-bb0a-e053-d805fe0a78d9
|
14
|
|
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), file dfe4d22d-b926-bb0a-e053-d805fe0a78d9
|
14
|
|
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients., file dfe4d229-40c3-bb0a-e053-d805fe0a78d9
|
13
|
|
Chronic Total Coronary Occlusions: Stress Echocardiography with Speckle Tracking Analysis Study, file dfe4d229-82d4-bb0a-e053-d805fe0a78d9
|
13
|
|
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease, file dfe4d22b-b249-bb0a-e053-d805fe0a78d9
|
13
|
|
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis., file dfe4d22b-e1d8-bb0a-e053-d805fe0a78d9
|
13
|
|
Transcatheter aortic valve implantation with a mechanical-expandable device: When perfection is hung on a 'wire', file dfe4d22b-fae6-bb0a-e053-d805fe0a78d9
|
13
|
|
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds, file dfe4d22b-5e4c-bb0a-e053-d805fe0a78d9
|
12
|
|
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry, file dfe4d22b-612a-bb0a-e053-d805fe0a78d9
|
12
|
|
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial, file dfe4d22b-d0b1-bb0a-e053-d805fe0a78d9
|
12
|
|
Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement, file dfe4d22c-12a6-bb0a-e053-d805fe0a78d9
|
12
|
|
Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement, file dfe4d22c-24eb-bb0a-e053-d805fe0a78d9
|
12
|
|
A Bicuspid Aortic Valve Imaging Classification for the TAVR Era, file dfe4d22c-24ec-bb0a-e053-d805fe0a78d9
|
12
|
|
Embolization of fractured bioresorbable scaffold struts: insights from 2- and 3-dimensional optical coherence tomography, file dfe4d22a-7594-bb0a-e053-d805fe0a78d9
|
11
|
|
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality?, file dfe4d22b-18e0-bb0a-e053-d805fe0a78d9
|
11
|
|
3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO), file dfe4d22b-7ac2-bb0a-e053-d805fe0a78d9
|
11
|
|
Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study, file dfe4d22b-cdd4-bb0a-e053-d805fe0a78d9
|
11
|
|
Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry, file dfe4d22c-2bdf-bb0a-e053-d805fe0a78d9
|
11
|
|
Bioresorbable vascular scaffolds in left main coronary artery disease, file dfe4d22a-f660-bb0a-e053-d805fe0a78d9
|
10
|
|
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement, file dfe4d22b-911f-bb0a-e053-d805fe0a78d9
|
10
|
|
Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds, file dfe4d22b-b48c-bb0a-e053-d805fe0a78d9
|
10
|
|
Update on clinical evidence (Part II): a summary of the main post market studies, file dfe4d22b-e099-bb0a-e053-d805fe0a78d9
|
10
|
|
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery, file dfe4d22a-f65d-bb0a-e053-d805fe0a78d9
|
9
|
|
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography, file dfe4d22b-13b9-bb0a-e053-d805fe0a78d9
|
9
|
|
The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients, file dfe4d22b-6e61-bb0a-e053-d805fe0a78d9
|
9
|
|
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis, file dfe4d22c-12ab-bb0a-e053-d805fe0a78d9
|
9
|
|
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long term outcome after implantation of drug–eluting stents, file dfe4d227-06d9-bb0a-e053-d805fe0a78d9
|
8
|
|
STENTYS Self-Apposing sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial., file dfe4d22a-b840-bb0a-e053-d805fe0a78d9
|
8
|
|
Longitudinal elongation, axial compression, and effects on strut geometry of bioresorbable vascular scaffolds: insights from 2- and 3-dimensional optical coherence tomography imaging, file dfe4d22a-e183-bb0a-e053-d805fe0a78d9
|
8
|
|
Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients, file dfe4d22b-7ac4-bb0a-e053-d805fe0a78d9
|
8
|
|
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations, file dfe4d22b-a891-bb0a-e053-d805fe0a78d9
|
8
|
|
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI, file dfe4d22d-289f-bb0a-e053-d805fe0a78d9
|
8
|
|
Reference Renal Artery Diameter Is a Stronger Predictor of Contrast-Induced Nephropathy than Chronic Kidney Disease in Patients with High Cardiovascular Risk, file dfe4d229-ef47-bb0a-e053-d805fe0a78d9
|
7
|
|
Current Status and Clinical Development of Transcatheter Approaches for Severe Mitral Regurgitation, file dfe4d22a-d1e9-bb0a-e053-d805fe0a78d9
|
7
|
|
Fate of Coronary Chronic Total Occlusion Recanalization via Subintimal Tracking With Bioresorbable Vascular Scaffolds: A Temporary Cage for a Permanent New Lumen?, file dfe4d22b-558b-bb0a-e053-d805fe0a78d9
|
7
|
|
Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation, file dfe4d22b-5abf-bb0a-e053-d805fe0a78d9
|
7
|
|
Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement in Low-Risk Patients., file dfe4d22b-d7db-bb0a-e053-d805fe0a78d9
|
7
|
|
Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis., file dfe4d22c-1109-bb0a-e053-d805fe0a78d9
|
7
|
|
Feasibility, reproducibility, and agreement between different speckle tracking echocardiographic techniques for the assessment of longitudinal deformation., file dfe4d226-fdd8-bb0a-e053-d805fe0a78d9
|
6
|
|
Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry"., file dfe4d22b-d622-bb0a-e053-d805fe0a78d9
|
6
|
|
Left Atrial Strain Imaging by Speckle Tracking Echocardiography: The Supportive Diagnostic Value in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy, file 34e98f60-5506-4406-96a6-4a3a0259ae5c
|
5
|
|
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial, file 8612fa32-74cb-4440-8a20-adc949936ce1
|
5
|
|
Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study, file dfe4d22b-76c9-bb0a-e053-d805fe0a78d9
|
5
|
|
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry, file dfe4d22b-8c39-bb0a-e053-d805fe0a78d9
|
5
|
|
Impact of Anesthesia Type on Outcomes of Transcatheter Aortic Valve Implantation (from the Multicenter ADVANCE Study)., file dfe4d22b-9c18-bb0a-e053-d805fe0a78d9
|
5
|
|
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients, file dfe4d22b-a2ab-bb0a-e053-d805fe0a78d9
|
5
|
|
Prevalence and morphological changes of carotid kinking and coiling in growth: an echo-color Doppler study of 2856 subjects between aged 0 to 96 years, file 02450010-66f0-4eff-a67d-4155d4cf80be
|
4
|
|
Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures, file 2b653943-5ed7-4667-98e7-0e9836acb077
|
4
|
|
Transient impairment of vasomotion function after successful chronic total occlusion recanalization, file dfe4d227-0a89-bb0a-e053-d805fe0a78d9
|
4
|
|
Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: A prospective, randomized, multicenter study, file dfe4d227-124d-bb0a-e053-d805fe0a78d9
|
4
|
|
Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study, file 404b30e8-a585-47c1-830d-4f9a690a3c3a
|
3
|
|
Cardiovascular Magnetic Resonance for the Assessment of Patients undergoing Transcatheter Aortic Valve Implantation: A Pilot Study, file c41b2a33-e16f-4f8a-8305-3253d34d76f0
|
3
|
|
Anterograde techniques for percutaneous revascularization of chronic total coronary occlusions, file dfe4d227-1509-bb0a-e053-d805fe0a78d9
|
3
|
|
Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions: the reality trial: a randomized controlled trial, file dfe4d227-19fb-bb0a-e053-d805fe0a78d9
|
3
|
|
Late device dislodgement after percutaneous closure of mitral prosthesis paravalvular leak with amplatzer muscular ventricular septal defect occluder, file dfe4d227-402a-bb0a-e053-d805fe0a78d9
|
3
|
|
Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting, file dfe4d227-7d0d-bb0a-e053-d805fe0a78d9
|
3
|
|
Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion, file dfe4d227-bba9-bb0a-e053-d805fe0a78d9
|
3
|
|
Incidence and Potential Mechanism of Resolved, Persistent and Newly Acquired Malapposition 3 days after Implantation of Self-expanding or Balloon-expandable Stent in STEMI population: insights from Optical Coherence Tomography in the Apposition II study, file dfe4d22b-7a49-bb0a-e053-d805fe0a78d9
|
3
|
|
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment, file dfe4d22b-8414-bb0a-e053-d805fe0a78d9
|
3
|
|
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry., file dfe4d22b-89f3-bb0a-e053-d805fe0a78d9
|
3
|
|
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective., file dfe4d22b-8a9c-bb0a-e053-d805fe0a78d9
|
3
|
|
Renal artery diameter, renal function and resistant hypertension in patients with low-to-moderate renal artery stenosis, file dfe4d227-066e-bb0a-e053-d805fe0a78d9
|
2
|
|
Retrograde approach for chronic total occlusion percutaneous revascularization, file dfe4d227-1058-bb0a-e053-d805fe0a78d9
|
2
|
|
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity., file dfe4d227-1fe1-bb0a-e053-d805fe0a78d9
|
2
|
|
Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgment, file dfe4d227-2305-bb0a-e053-d805fe0a78d9
|
2
|
|
Clinical features of transient left ventricular apical ballooning, file dfe4d227-3973-bb0a-e053-d805fe0a78d9
|
2
|
|
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention, file dfe4d227-3a14-bb0a-e053-d805fe0a78d9
|
2
|
|
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease, file dfe4d227-93e3-bb0a-e053-d805fe0a78d9
|
2
|
| Totale |
5.214 |